GE HealthCare Technologies Inc. (GEHC) Financial Statements
Industry: X-Ray Apparatus & Tubes & Related Irradiation Apparatus
In fiscal 2025, GE HealthCare Technologies reported revenue of $20.62B, up 4.8% from $19.67B the year before. Net income was $2.08B (a 10.1% net margin), or $4.55 per diluted share. Gross margin was 40.0% and operating margin was 13.4%. Operating activities generated $1.99B of cash, leaving $1.50B of free cash flow. At fiscal year end, GE HealthCare Technologies held $36.91B in total assets against $26.31B in total liabilities, including $4.49B of cash and equivalents.
Open the full interactive GE HealthCare Technologies financials → Quarterly statements, key ratios, valuation history and price charts.
GE HealthCare Technologies Key Stats
| Share Price | $68.79 |
|---|---|
| Market Cap | $31.23B |
| P/E Ratio | 15.1 |
| Dividend Yield | 0.20% |
| Revenue YoY Growth | +4.8% |
| 52-Week Range | $59.45 – $88.03 |
| Shares Outstanding | 453.0 million (basic, 2026 Q2) |
GE HealthCare Technologies Income Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Revenue | $19.55B | $19.67B | $20.62B |
| Gross Profit | $7.92B | $8.21B | $8.25B |
| Operating Income | $2.44B | $2.62B | $2.76B |
| Pre-Tax Income | $2.36B | $2.58B | $2.77B |
| Income Tax | $743.0M | $531.0M | $614.0M |
| Net Income | $1.57B | $1.99B | $2.08B |
| Diluted EPS | $3.03 | $4.34 | $4.55 |
GE HealthCare Technologies Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $5.14B | $5.70B | $5.13B | $5.29B |
| Net Income | $446.0M | $588.0M | $389.0M | $561.0M |
| Diluted EPS | $0.98 | $1.28 | $0.85 | $1.24 |
GE HealthCare Technologies Balance Sheet
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash & Equivalents | $2.49B | $2.87B | $4.49B |
| Current Assets | $9.41B | $9.90B | $12.50B |
| Total Assets | $32.45B | $33.09B | $36.91B |
| Current Liabilities | $8.98B | $9.55B | $9.11B |
| Total Long-Term Debt | $9.44B | $8.95B | $10.00B |
| Total Liabilities | $25.14B | $24.44B | $26.31B |
| Shareholders' Equity | $7.13B | $8.45B | $10.38B |
GE HealthCare Technologies Cash Flow Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash From Operations | $2.10B | $1.96B | $1.99B |
| Cash From Investing | -$558.0M | -$914.0M | -$1.05B |
| Cash From Financing | -$478.0M | -$573.0M | $617.0M |
| Free Cash Flow | $1.71B | $1.55B | $1.50B |
| Dividends Paid | $41.0M | $55.0M | $64.0M |
Figures from GE HealthCare Technologies' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full GE HealthCare Technologies financials page for every line item.
GE HealthCare Technologies Company Profile
| Ticker | GEHC |
|---|---|
| Exchange | Nasdaq |
| Industry | X-Ray Apparatus & Tubes & Related Irradiation Apparatus |
| Headquarters | Chicago, Illinois |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001932393 |
Frequently Asked Questions
What was GE HealthCare Technologies' revenue in fiscal 2025?
GE HealthCare Technologies (GEHC) reported revenue of $20.62B for fiscal 2025.
What is GE HealthCare Technologies' annual revenue history?
GE HealthCare Technologies' annual revenue by fiscal year: 2023: $19.55B; 2024: $19.67B; 2025: $20.62B.
What was GE HealthCare Technologies' net income in fiscal 2025?
GE HealthCare Technologies reported net income of $2.08B for fiscal 2025.
What was GE HealthCare Technologies' earnings per share (EPS) in fiscal 2025?
GE HealthCare Technologies' diluted EPS was $4.55 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did GE HealthCare Technologies generate in fiscal 2025?
GE HealthCare Technologies generated $1.50B of free cash flow in fiscal 2025.
What was GE HealthCare Technologies' revenue last quarter?
In its most recent reported quarter (2026 Q2), GE HealthCare Technologies reported revenue of $5.29B.
How much debt does GE HealthCare Technologies have?
GE HealthCare Technologies reported $10.00B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of GE HealthCare Technologies are outstanding?
GE HealthCare Technologies reported a weighted average of 453.0 million basic shares outstanding in 2026 Q2.
What is GE HealthCare Technologies' market cap?
Based on its latest closing price, GE HealthCare Technologies (GEHC) has a market capitalization of about $31.23B.
When does GE HealthCare Technologies' fiscal year end?
GE HealthCare Technologies' fiscal year end, as registered with the SEC, is December 31.
Where is GE HealthCare Technologies headquartered?
GE HealthCare Technologies lists its business address in Chicago, Illinois in its SEC filings.